ArticleACS materials letters2023
Shape-Memory Effect Triggered by π-π Interactions in a Flexible Terpyridine Metal-Organic Framework.
Article in ACS materials letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shape-memory polymers and alloys are adaptable materials capable of reversing from a deformed, metastable phase to an energetically favored original phase in response to external stimuli. In the context of metal-organic frameworks, the term shape-memory is defined as the property of a switchable framework to stabilize the reopened pore phase after the first switching transition. Herein we describe a novel flexible terpyridine MOF which, upon desolvation, transforms into a nonporous structure that reopens into a shape-memory phase when exposed to CO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.